EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Long-term echocardiographic data, mechanisms of failure, and reintervention outcomes of the Epic valve in mitral position—a large observational cohort

Jérémy Bernard, Dimitri Kalavrouziotis, Erwan Salaun, Shervin Babaki, Marie-Annick Clavel, Josep Rodés-Cabau, Philippe Pibarot, Siamak Mohammadi

The Journal of Thoracic and Cardiovascular Surgery · 2023

DOI: 10.1016/j.jtcvs.2023.06.019 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023. Verfasst von Jérémy Bernard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec, Quebec, Canada. Hauptthemen laut MEDLINE: Heart Valve Prosthesis Implantation, Heart Valve Prosthesis, Endocarditis, Bioprosthesis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Long-term echocardiographic reports on mitral valve (MV) porcine xenograft bioprosthesis (Epic) are lacking, and postreintervention outcomes of failed Epic are unknown. We aimed to assess the mechanisms and independent predictors of Epic failures and to compare short- and mid-term outcomes according to reintervention type. METHODS: We included consecutive patients (n = 1397; mean age: 72 ± 8 years; 46% female; mean follow-up: 4.8 years) who received the Epic during mitral valve replacement (MVR) at our institution. Clinical, echocardiographic, reintervention, and outcomes data were retrieved from our prospective institution's database or government statistics. RESULTS: Gradients and effective orifice area of the Epic were stable over 5-years follow-up. A total of 70 (5%) patients had a MV reintervention at median follow-up of 3.0 (0.7-5.4) years due to prosthesis failure, by redo-MVR (n = 38; 54%), valve-in-valve (n = 19; 27%), paravalvular leak (PVL) closure (n = 12; 17%), or thrombectomy (n = 1). Mechanisms of failure were 27 (1.9%) structural valve deterioration (SVD; all leaflet tear); 16 (1.1%) non-SVD (15 PVL, 1 pannus); 24 (1.7%) endocarditis; and 4 (0.3%) thrombosis. Freedom from all-cause and SVD-related MV reintervention at 10 years are 88% and 92%, respectively. Independent predictors of reintervention were age, baseline atrial fibrillation, initial MV etiology, and moderate or greater PVL at discharge (all P ≤ .05). Comparison of redo-MVR and valve-in-valve revealed no significant difference in early outcomes or mid-term mortality (all P ≥ .16). CONCLUSIONS: The Epic Mitral valve has stable hemodynamics through 5 years and is associated with low incidence of SVD and reintervention, mostly due to endocarditis and leaflet tear without calcification. Reintervention type had no influence on early outcomes and mid-term mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve Prosthesis ImplantationHeart Valve ProsthesisEndocarditisBioprosthesisAnimalsSwineHumansFemaleMiddle AgedAgedAged, 80 and overMaleProspective StudiesProsthesis FailureEchocardiographyAortic ValveFollow-Up StudiesProsthesis DesignTreatment Outcome

Stichwörter der Autor:innen

echocardiographymitral valve hemodynamicsmitral valve replacementporcine bioprosthesisprosthesis failurereintervention

Autor:innen und Institutionen

  • Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec, Quebec, Canada.
  • Cardiac Surgery Division, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec, Quebec, Canada.
  • Cardiac Surgery Research Section of the Quebec Heart and Lung Institute, Laval University, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec, Quebec, Canada.
  • Cardiac Surgery Division, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Quebec, Quebec, Canada. Electronic address: siamak.mohammadi@fmed.ulaval.ca.

Zitieren

APA

Bernard, J., Kalavrouziotis, D., Salaun, E., Babaki, S., Clavel, M. A., Rodés-Cabau, J., Pibarot, P., & Mohammadi, S. (2023). Long-term echocardiographic data, mechanisms of failure, and reintervention outcomes of the Epic valve in mitral position—a large observational cohort. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.06.019

Vancouver

Bernard J, Kalavrouziotis D, Salaun E, Babaki S, Clavel MA, Rodés-Cabau J, et al. Long-term echocardiographic data, mechanisms of failure, and reintervention outcomes of the Epic valve in mitral position—a large observational cohort. The Journal of Thoracic and Cardiovascular Surgery. 2023. doi:10.1016/j.jtcvs.2023.06.019

BibTeX
@article{Bernard2023,
  author = {Bernard, Jérémy and Kalavrouziotis, Dimitri and Salaun, Erwan and Babaki, Shervin and Clavel, Marie-Annick and Rodés-Cabau, Josep and Pibarot, Philippe and Mohammadi, Siamak},
  title = {Long-term echocardiographic data, mechanisms of failure, and reintervention outcomes of the Epic valve in mitral position—a large observational cohort},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2023},
  doi = {10.1016/j.jtcvs.2023.06.019}
}
Kostenlos starten →